| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0076 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |